title: Managing musculoskeletal infections in children in the era of increasing bacterial resistance.
abstract: The continually changing spectrum of bacterial resistance in children with musculoskeletal infections underscores the importance of prompt diagnosis coupled with timely and appropriate treatment. This article focuses on two serious childhood musculoskeletal infections commonly encountered by primary care providers: acute hematogenous osteomyelitis and septic arthritis.
authors.affiliation: David R. Godley is a pediatric orthopedic surgeon at Kaiser San Jose (Calif.) Medical Center. The author has disclosed no potential conflicts of interest, financial or otherwise.
authors.forename: David R
authors.initials: DR
authors.lastname: Godley
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001170:Arthritis, Infectious / Q000382:microbiology / Q000628:therapy*; D016470:Bacteremia / Q000382:microbiology / Q000628:therapy*; D002648:Child; D003646:Debridement; D004322:Drainage; D024881:Drug Resistance, Bacterial; D004754:Enterobacter; D004756:Enterobacteriaceae Infections / Q000382:microbiology / Q000628:therapy; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus; D010019:Osteomyelitis / Q000382:microbiology / Q000628:therapy*; D013203:Staphylococcal Infections / Q000382:microbiology / Q000628:therapy; D013211:Staphylococcus aureus; D013290:Streptococcal Infections / Q000382:microbiology / Q000628:therapy; D013296:Streptococcus pneumoniae; D013297:Streptococcus pyogenes
chemical_list: D000900:Anti-Bacterial Agents